CLDN5 and depressive symptom measurement: Similarly, postmortem studies suggest that CLDN5 protein is reduced in the hippocampi of men and women with depression and schizophrenia, with greater reductions in CLDN5 expression as a function of more years of chronic psychiatric symptoms (Greene et al., 2020).